Intelligence Β· Clinical Pipeline

Xenon Pharmaceuticals Pipeline

All ClinicalTrials.gov programs at Xenon Pharmaceuticals β€” phase, modality, and trial IDs.

Programs
22

Quick answer

Xenon Pharmaceuticals has 22 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Azetukalner

    Xenon Pharmaceuticals

    Bipolar Depression

    phase 3 small molecule active

    1 trial
  2. Azetukalner

    Xenon Pharmaceuticals

    Major Depressive Disorder

    phase 3 small molecule active

    3 trials
  3. Azetukalner

    Xenon Pharmaceuticals

    Bipolar Disorder

    phase 3 small molecule active

    1 trial
  4. Placebo, XPF-010

    Xenon Pharmaceuticals

    Depressive episodes associated with Bipolar disorder I or II (Bipolar Depression)

    phase 3 small molecule active

    1 trial
  5. XEN1101

    Xenon Pharmaceuticals

    Primary Generalized Tonic-Clonic Seizures

    phase 3 small molecule active

    1 trial
  6. XEN1101

    Xenon Pharmaceuticals

    Focal Epilepsy

    phase 3 small molecule active

    2 trials
  7. XEN1101

    Xenon Pharmaceuticals

    Focal Onset Seizures

    phase 3 small molecule active

    2 trials
  8. XEN496

    Xenon Pharmaceuticals

    Epilepsy

    phase 3 small molecule terminated

    2 trials
  9. XPF-010

    Xenon Pharmaceuticals

    Depressive episodes associated with Bipolar disorder I or II (Bipolar Depression)

    phase 3 small molecule active

    1 trial
  10. XPF-010, Placebo to match XPF-010

    Xenon Pharmaceuticals

    Major Depressive Disorder

    phase 3 small molecule active

    1 trial
  11. XEN1101 10 mg

    Xenon Pharmaceuticals

    Major Depressive Disorder

    phase 2 small molecule completed

    1 trial
  12. XPF-001

    Xenon Pharmaceuticals

    Dental Pain

    phase 2 small molecule completed

    1 trial
  13. XPF-001

    Xenon Pharmaceuticals

    Primary Erythromelalgia

    phase 2 small molecule completed

    1 trial
  14. XPF-002

    Xenon Pharmaceuticals

    Primary Erythromelalgia

    phase 2 small molecule completed

    1 trial
  15. XPF-002

    Xenon Pharmaceuticals

    Postherpetic Neuralgia

    phase 2 small molecule completed

    1 trial
  16. XPF-005

    Xenon Pharmaceuticals

    Acne Vulgaris

    phase 2 small molecule completed

    1 trial
  17. XPF-010, XPF-008, XEN1101 placebo

    Xenon Pharmaceuticals

    Adult focal (partial onset) epilepsy

    phase 2 small molecule active

    1 trial
  18. 14C-XEN1101

    Xenon Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  19. XEN901

    Xenon Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  20. XPF-001

    Xenon Pharmaceuticals

    Healthy Human Volunteers

    phase 1 small molecule completed

    1 trial
  21. XPF-008

    Xenon Pharmaceuticals

    Healthy Male Volunteers

    phase 1 small molecule completed

    1 trial
  22. XPF-008

    Xenon Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does Xenon Pharmaceuticals have?

22 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs